QuiVad

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Zealand Pharma A/SDenmark1.11%May 19, 2026
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.63%July 3, 2026
Gubra A/SDenmark0.59%March 23, 2026
Lang & Schwarz AktiengesellschaftGermany0.59%February 2, 2022
Tubacex, S.A.Spain0.59%June 30, 2026
Medigene AGGermany0.55%December 4, 2017
Atos GroupFrance0.50%July 21, 2026
SFC Energy AGGermany0.49%August 12, 2026

History of disclosures

6109 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
July 28, 2017ViridienFrance0.59%August 25, 2017
July 27, 2017ViridienFrance0.60%August 25, 2017
July 24, 2017ViridienFrance0.51%August 25, 2017
July 5, 2017ViridienFrance0.37%July 7, 2017
June 23, 2017ViridienFrance0.51%July 7, 2017
June 22, 2017Medigene AGGermany0.49%still open
June 21, 2017Medigene AGGermany0.59%still open
June 14, 2017Medigene AGGermany0.60%still open
June 12, 2017Medigene AGGermany0.51%still open

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at August 12, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=123